Sort by
Keyphrases
Clinically Significant
100%
Drug Screening
100%
Primary Hepatocytes
100%
Cytochrome P450 3A4 (CYP3A4)
100%
CYP3A4 Induction
100%
Three-dimensional Spheroid Culture
100%
Induction Mechanism
100%
CYP3A4 Inducer
66%
Pregnane X Receptor
50%
AZD1208
50%
Monolayer Culture
33%
Two-dimensional Monolayer
33%
Drug Development
16%
Epidermal Growth Factor
16%
Mechanistic Studies
16%
Drug Interactions
16%
Drug Candidates
16%
Physiologically Relevant
16%
Phosphorylation
16%
Autoinduction
16%
ERK2
16%
Early Identification
16%
Cytochrome P450 2D6 (CYP2D6)
16%
Gene Knockout
16%
Tyrosine
16%
Negative Control
16%
Epidermal Growth Factor Receptor
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Lapatinib
16%
Hepatocyte Spheroid
16%
Rifampicin
16%
Phenobarbital
16%
Extracellular Signal-regulated Kinase Pathway
16%
Nuclear Receptor Activation
16%
Screening Model
16%
3D Spheroids
16%
Integration Site
16%
Moloney murine Leukemia Virus
16%
Constitutive Androstane Receptor
16%
Viral Integration
16%
Pim Kinase Inhibitor
16%
Mitogen-activated Protein Kinase/extracellular Signal-regulated Kinase
16%
Medicine and Dentistry
Drug Screening
100%
Hepatocyte
100%
CYP3A4
100%
Tumor Spheroid
100%
Pregnane X Receptor
20%
Mitogen-Activated Protein Kinase
13%
Epidermal Growth Factor Receptor
6%
Phosphotransferase Inhibitor
6%
Epidermal Growth Factor
6%
CYP2B6
6%
Epidermal Growth Factor Receptor 2
6%
Gamma Urogastrone
6%
Lapatinib
6%
Mitogen Activated Protein Kinase 3
6%
Cell Nucleus Receptor
6%
Aciclovir
6%
Phenobarbital
6%
Moloney Murine Leukemia Virus
6%
Constitutive Androstane Receptor
6%
Gene Knockdown
6%
Rifampicin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Screening
100%
CYP3A4
100%
Pregnane X Receptor
20%
Mitogen Activated Protein Kinase
13%
Epidermal Growth Factor Receptor
6%
Epidermal Growth Factor
6%
Phosphotransferase Inhibitor
6%
CYP2B6
6%
Drug Development
6%
Mitogen Activated Protein Kinase 3
6%
Aciclovir
6%
Gamma Urogastrone
6%
Rifampicin
6%
Epidermal Growth Factor Receptor 2
6%
Phenobarbital
6%
Lapatinib
6%
Cell Nucleus Receptor
6%
Moloney Murine Leukemia Virus
6%
Constitutive Androstane Receptor
6%